1. Home
  2. CRSP vs WFG Comparison

CRSP vs WFG Comparison

Compare CRSP & WFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$50.24

Market Cap

5.1B

Sector

Health Care

ML Signal

HOLD

Logo West Fraser Timber Co. Ltd.

WFG

West Fraser Timber Co. Ltd.

HOLD

Current Price

$76.54

Market Cap

4.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
WFG
Founded
2013
1955
Country
Switzerland
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
4.6B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CRSP
WFG
Price
$50.24
$76.54
Analyst Decision
Buy
Strong Buy
Analyst Count
20
3
Target Price
$71.95
$93.00
AVG Volume (30 Days)
1.8M
278.0K
Earning Date
02-11-2026
02-11-2026
Dividend Yield
N/A
1.78%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$38,337,000.00
$5,702,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,376.73
$9.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.04
$57.34
52 Week High
$78.48
$86.88

Technical Indicators

Market Signals
Indicator
CRSP
WFG
Relative Strength Index (RSI) 40.76 74.48
Support Level $49.10 $67.73
Resistance Level $53.00 $71.22
Average True Range (ATR) 3.12 2.10
MACD -0.48 0.21
Stochastic Oscillator 12.40 95.67

Price Performance

Historical Comparison
CRSP
WFG

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About WFG West Fraser Timber Co. Ltd.

West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is one of the largest oriented strand board producers in the world.

Share on Social Networks: